Personalis at European NeoAG Summit 2019: April 24-25


Wednesday, APR 24 | 2:30 PM CEST 

Sean Michael Boyle, PhD
Director, Bioinformatics Applications
Personalis, Inc.

ImmunoID NeXT Platform: Improving Neoantigen Prediction, TME Assessment, and ctDNA Detection for Vaccine Development

  • Innovative genomics methods for more comprehensive assessment of neoantigens
  • Improving neoantigen to MHC binding prediction and ranking
  • Assessing TME/TCR and tumor escape mechanisms that may impact vaccine response